Results 1 to 10 of about 2,925,264 (406)

Comparison of disease free survival in breast cancer molecular subtypes [PDF]

open access: yesCaspian Journal of Internal Medicine
Background: Breast cancer management depends on molecular subtypes. The aim was to compare disease-free survival (DFS) among the different subgroups. Overall survival (OS) is a secondary endpoint.
Maryam Esmati   +6 more
doaj   +4 more sources

Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer. [PDF]

open access: yesBMC Cancer
Abstract Background Obese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear. This study aimed to investigate different effects of Body Mass Index (BMI) on prognosis disease-free survival and overall survivor of breast cancer patients.
Zangouri V   +7 more
europepmc   +4 more sources

Meta‐Analysis of Recurrence‐Free Survival or Disease‐Free Survival as a Potential Surrogate Endpoint for Overall Survival in Esophageal Cancer Trials [PDF]

open access: yesCancer Reports
Background Cancer trials increasingly use surrogate endpoints, but it is unclear how well recurrence‐free survival (RFS) or disease‐free survival (DFS) specifically predict overall survival (OS) in resectable esophageal cancer (EC).
Uchechukwu Love Anyaduba   +5 more
doaj   +2 more sources

Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer [PDF]

open access: yesAnnals of Coloproctology, 2021
Purpose It is known that as the T stage of a carcinoma progresses, the prognosis becomes poorer. However, there are few studies about factors that affect the prognosis of T4 advanced colon cancer.
Taeyeong Eom   +8 more
doaj   +5 more sources

Local Disease-Free Survival and Disease-Free Survival in Locally Advanced Cervical Cancer Diagnosed and Treated in Bihor County, Romania. [PDF]

open access: yesCureus
Cervical cancer is the fourth most dangerous malignancy worldwide in women and is diagnosed at the advanced stages in most cases. Oncological and surgical modalities when precisely employed together can prove to be helpful for determining the proper diagnosis and treatment strategies.
Molnar O   +6 more
europepmc   +3 more sources

Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients

open access: yesCancer Cell International, 2019
Background Increasing evidences supported the association between long non-coding RNA (lncRNA) and disease free survival in gastric cancer (GC) patients.
Canchang Cheng   +4 more
doaj   +2 more sources

Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review [PDF]

open access: yesReviews in Clinical Medicine, 2015
Introduction: The prognostic value of Her2-positive expression has been investigated for malignancies such as breast cancer. We aimed to study the association between Her2 gene overexpression and clinical progression of hormone-independent prostate ...
Mozhgan Moghadas niyat
doaj   +3 more sources

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer [PDF]

open access: yesObstetrics & Gynecology Science, 2020
Objective Epithelial ovarian cancer (EOC) is rarely detected at stage 1a. Most of the patients have a good prognosis and there are limited factors that affect their survival. In the present study, we evaluated the p16 and p53 gene expressions of stage 1a
Emre Günakan   +5 more
doaj   +1 more source

Prognostic value of peripheral blood lymphocyte subsets in patients with solid cancers: a retrospective study [PDF]

open access: yesArchives of the Balkan Medical Union, 2021
Introduction. Lymphocyte subsets are important in regulating immunity and specific killing of tumour cells and appear to be strongly associated with the development of solid tumours.
Marieta-Elena PANAIT   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy